Factors associated with postprandial lipemia and apolipoprotein a-v levels in individuals with familial combined hyperlipidemia

BMC Endocrine Disorders

Volumn 14, Issue 1, 2014, Pages

  Almeda Valdes, Paloma ^a   Cuevas Ramos, Daniel ^a   Mehta, Roopa ^a   Muñoz Hernandez, Liliana ^a   Cruz Bautista, Ivette ^a   Perez Mendez, Oscar ^b   Tusie Luna, Maria Teresa ^c   Gomez Perez, Francisco J ^a   Pajukanta, Päivi ^d   Matikainen, Niina ^e   Taskinen, Marja Riitta ^e   Aguilar Salinas, Carlos A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Abdominal obesity; Apo A V; Apo B 48; Postprandial lipemia; Triglycerides; Waist to hip ratio

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A-V; APOLIPOPROTEIN B48; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADULT; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL HYPERLIPEMIA; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; POSTPRANDIAL LIPEMIA; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

EID: 84924336747     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-14-90     Document Type: Article

References (28)

1. Goldberg IJ, Eckel RH, McPherson R: Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol 2011, 31(8):1716-1725.
2. Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, Russell RM, Schaefer EJ: Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993, 34(12):2033-2040.
3. Hwu CM, Lin MW, Liou TL, Hsiao LC, Liang KW, Tsai TT, Ho LT: Fasting triglyceride is a major determinant of postprandial triglyceride response in postmenopausal women. Menopause 2008, 15(1):150-156.
4. Tan KC, Tso AW, Ma OC, Pang RW, Tam S, Lam KS: Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes. Diabetes Metab Res Rev 2005, 21(2):209-214.
5. van Wijk JP, Halkes CJ, Erkelens DW, Castro Cabezas M: Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metab Clin Exp 2003, 52(8):1043-1049.
6. Pirro M, Lupattelli G, Siepi D, Palumbo B, Roscini AR, Marchesi S, Schillaci G, Mannarino E: Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women. Metab Clin Exp 2001, 50(3):330-334.
7. Sharma V, Forte TM, Ryan RO: Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol. Curr Opin Lipidol 2013, 24(2):153-159.
8. van Dijk KW, Rensen PC, Voshol PJ, Havekes LM: The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr Opin Lipidol 2004, 15(3):239-246.
9. Aguilar Salinas CA, Zamora M, Gomez-Diaz RA, Mehta R, Gomez Perez FJ, Rull JA: Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis. Semin Vasc Med 2004, 4(2):203-209.
10. Carr MC, Brunzell JD: Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004, 89(6):2601-2607.
11. Castro Cabezas M: Postprandial lipaemia in familial combined hyperlipidaemia. Biochem Soc Trans 2003, 31(Pt 5):1090-1093.
12. Valles V, Aguilar-Salinas CA, Gomez-Perez FJ, Rojas R, Franco A, Olaiz G, Rull JA, Sepulveda J: Apolipoprotein B and A-I distribution in Mexican urban adults: results of a nationwide survey. Metab Clin Exp 2002, 51(5):560-568.
13. del Rincon Jarero JP, Aguilar-Salinas CA, Guillen-Pineda LE, Gomez-Perez FJ, Rull JA: Lack of agreement between the plasma lipid-based criteria and apoprotein B for the diagnosis of familial combined hyperlipidemia in members of familial combined hyperlipidemia kindreds. Metab Clin Exp 2002, 51(2):218-224.
14. Mata P, Alonso R, Ruiz Garcia A, Diaz Diaz JL, Gonzalez N, Gijon Conde T, Martinez Faedo C, Moron I, Arranz E, Aguado R, Argueso R, Perez de Isla L: Familial combined hyperlipidemia: consensus document. Atencion Primaria Sociedad Espanola Medicina Familia y Comunitaria 2014, 46(8):440-446.
15. Syvanne M, Talmud PJ, Humphries SE, Fisher RM, Rosseneu M, Hilden H, Taskinen MR: Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol. J Lipid Res 1997, 38(7):1463-1472.
16. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
18. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22(9):1462-1470.
19. Maki KC, Kelley KM, Lawless AL, Hubacher RL, Schild AL, Dicklin MR, Rains TM: Validation of insulin sensitivity and secretion indices derived from the liquid meal tolerance test. Diabetes Technol Ther 2011, 13(6):661-666.
20. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, Tsarpalis K, Damaskos DS, Manolis A, Cokkinos DV: Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis 2005, 4:21.
21. Sharrett AR, Heiss G, Chambless LE, Boerwinkle E, Coady SA, Folsom AR, Patsch W: Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001, 21(2):275-281.
22. Guerci B, Verges B, Durlach V, Hadjadj S, Drouin P, Paul JL: Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients. Int J Obes Relat Metab Disord 2000, 24(4):468-478.
23. Meijssen S, Cabezas MC, Twickler TB, Jansen H, Erkelens DW: In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia. J Lipid Res 2000, 41(7):1096-1102.
24. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294(5540):169-173.
25. Kahri J, Fruchart-Najib J, Matikainen N, Fruchart JC, Vakkilainen J, Taskinen MR: The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activity. Diabetes Care 2007, 30(8):2083-2085.
26. Ribalta J, Figuera L, Fernandez-Ballart J, Vilella E, Castro Cabezas M, Masana L, Joven J: Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 2002, 48(9):1597-1600.
27. O'Brien PJ, Alborn WE, Sloan JH, Ulmer M, Boodhoo A, Knierman MD, Schultze AE, Konrad RJ: The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 2005, 51(2):351-359.
28. Welborn TA, Dhaliwal SS: Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007, 61(12):1373-1379.